Scioderm, Inc. Report issue

For profit Phase 3
Founded: Durham NC United States (2012)
Status: Acquired by Amicus Therapeutics (2015)

Organization Overview

First Clinical Trial
2014
NCT02014376
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

sd-101 (3 trials)

Drugs in Other Trials (1)

zorblisa (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Epidermolysis Bullosa (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2